Annual Drug Patent Expirations for METROGEL
Metrogel is a drug marketed by Galderma Labs Lp and Bausch and is included in three NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for METROGEL.
This drug has twenty-six patent family members in nineteen countries.
The generic ingredient in METROGEL is metronidazole. Two suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com